Andrea L Cox

Johns Hopkins University

$41,369,991

Attributed

$43,837,491

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $11M · FY2005–25

$20M$15M$10M$5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$76,838,973 · 26

By mechanism

U19$36,078,993 · 15

T32$19,484,468 · 2

U54$11,788,435 · 4

R01$8,704,059 · 4

K08$783,018 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

David L Thomas$44,227,388
Shruti H Mehta$41,677,787
Justin Richard Bailey$16,021,335
Stuart C Ray$7,743,036
Gregory D Kirk$60,349,977

Others in their field

Top investigators on “Immune Response”

Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
Barton F Haynes · Duke University$456,664,915
Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665

Research focus

Immune ResponseInfectionVirusHepatitis C VirusViralResponsePersonsImmuneAntibodiesAcuteSpecimenImmunityResourcesPlasmaHepatitis CAcute Hepatitis CT-LymphocyteMediatingResearch PersonnelCohortCellsRecoveryPeripheral Blood Mononuclear CellScientist

Grant awards (119)

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$2,568,667

U19 · FY2025 · AI · contact PI

Medical Scientist Training Program$1,865,441

T32 · FY2025 · GM · contact PI

Immunologic and Metabolic Profiles of T cells that control diverse HCV infections$916,779

U19 · FY2025 · AI · contact PI

Dissecting Hepatitis B Vaccine Adjuvant Effects on Immune Responses and the HIV Reservoir in PLWH$822,489

R01 · FY2025 · AI · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$356,351

U19 · FY2025 · AI · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$62,294

U19 · FY2025 · AI · contact PI

Immunologic and Metabolic Profiles of T cells that control diverse HCV infections$62,294

U19 · FY2025 · AI · contact PI

Medical Scientist Training Program$60,545

T32 · FY2025 · GM · contact PI

Medical Scientist Training Program$60,545

T32 · FY2025 · GM · contact PI

Medical Scientist Training Program$60,545

T32 · FY2025 · GM · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$53,387

U19 · FY2025 · AI · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$2,630,987

U19 · FY2024 · AI · contact PI

Medical Scientist Training Program$1,917,949

T32 · FY2024 · GM · contact PI

Immunologic and Metabolic Profiles of T cells that control diverse HCV infections$827,166

U19 · FY2024 · AI · contact PI

Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)$759,945

U54 · FY2024 · CA

Dissecting Hepatitis B Vaccine Adjuvant Effects on Immune Responses and the HIV Reservoir in PLWH$744,728

R01 · FY2024 · AI · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$486,324

U19 · FY2024 · AI · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$145,944

U19 · FY2024 · AI · contact PI

Project 1: Mechanisms of innate sensing and pathogenesis of SARS-CoV-2$126,657

U54 · FY2024 · CA · contact PI

Medical Scientist Training Program$59,936

T32 · FY2024 · GM · contact PI

Medical Scientist Training Program$59,936

T32 · FY2024 · GM · contact PI

Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)$3,398,577

U54 · FY2023 · CA

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$2,630,982

U19 · FY2023 · AI · contact PI

Medical Scientist Training Program$1,857,713

T32 · FY2023 · GM · contact PI

Immunologic and Metabolic Profiles of T cells that control diverse HCV infections$820,384

U19 · FY2023 · AI · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$473,424

U19 · FY2023 · AI · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$145,440

U19 · FY2023 · AI · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$2,631,174

U19 · FY2022 · AI · contact PI

Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)$2,079,261

U54 · FY2022 · CA

Medical Scientist Training Program$1,825,157

T32 · FY2022 · GM · contact PI

Sex, obesity, immunometabolism, and viral persistence in post-acute sequelae of SARS-CoV-2 infection$1,209,546

U19 · FY2022 · AI · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$1,209,546

U19 · FY2022 · AI · contact PI

Immunologic and Metabolic Profiles of T cells that control diverse HCV infections$814,143

U19 · FY2022 · AI · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$473,349

U19 · FY2022 · AI · contact PI

Project 1: Mechanisms of innate sensing and pathogenesis of SARS-CoV-2$302,099

U54 · FY2022 · CA · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$145,438

U19 · FY2022 · AI · contact PI

Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)$119,719

U54 · FY2022 · CA

Admin-Core-001$119,719

U54 · FY2022 · CA

Medical Scientist Training Program$57,036

T32 · FY2022 · GM · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$2,632,704

U19 · FY2021 · AI · contact PI

Medical Scientist Training Program$1,720,412

T32 · FY2021 · GM · contact PI

Immunologic and Metabolic Profiles of T cells that control diverse HCV infections$817,644

U19 · FY2021 · AI · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$477,419

U19 · FY2021 · AI · contact PI

Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine$140,102

U19 · FY2021 · AI · contact PI

Medical Scientist Training Program$53,763

T32 · FY2021 · GM · contact PI

Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)$4,067,207

U54 · FY2020 · CA

Medical Scientist Training Program$1,702,579

T32 · FY2020 · GM · contact PI

Project 1: Mechanisms of innate sensing and pathogenesis of SARS-CoV-2$815,251

U54 · FY2020 · CA · contact PI

Mechanisms of repeated control of acute hepatitis C infection in humans$781,044

U19 · FY2020 · AI · contact PI

Scientific Core$279,095

U19 · FY2020 · AI · contact PI

Mechanisms of T cell control in repeated HCV infection and innate immune responses that drive them$140,230

U19 · FY2020 · AI · contact PI

Medical Scientist Training Program$53,206

T32 · FY2020 · GM · contact PI

Administrative Core$30,274

U19 · FY2020 · AI · contact PI

Medical Scientist Training Program$1,779,855

T32 · FY2019 · GM · contact PI

Mechanisms of repeated control of acute hepatitis C infection in humans$1,135,370

U19 · FY2019 · AI · contact PI

Immune correlates of acute HBV recovery with and without HIV$611,631

R01 · FY2019 · AI

Scientific Core$399,173

U19 · FY2019 · AI · contact PI

Mechanisms of T cell control in repeated HCV infection and innate immune responses that drive them$188,591

U19 · FY2019 · AI · contact PI

Medical Scientist Training Program$157,983

T32 · FY2019 · GM · contact PI

Administrative Core$53,333

U19 · FY2019 · AI · contact PI

Medical Scientist Training Program$1,876,677

T32 · FY2018 · GM · contact PI

Mechanisms of repeated control of acute hepatitis C infection in humans$794,328

U19 · FY2018 · AI · contact PI

Immune correlates of acute HBV recovery with and without HIV$616,491

R01 · FY2018 · AI

Scientific Core$279,636

U19 · FY2018 · AI · contact PI

Medical Scientist Training Program$156,390

T32 · FY2018 · GM · contact PI

Mechanisms of T cell control in repeated HCV infection and innate immune responses that drive them$137,360

U19 · FY2018 · AI · contact PI

Administrative Core$36,604

U19 · FY2018 · AI · contact PI

Medical Scientist Training Program$1,858,015

T32 · FY2017 · GM · contact PI

Mechanisms of repeated control of acute hepatitis C infection in humans$752,418

U19 · FY2017 · AI · contact PI

Immune correlates of acute HBV recovery with and without HIV$649,053

R01 · FY2017 · AI

Antibody-Mediated Suppression of Antiviral Inflammasome Activation$442,767

R01 · FY2017 · AI · contact PI

Scientific Core$266,709

U19 · FY2017 · AI · contact PI

Mechanisms of T cell control in repeated HCV infection and innate immune responses that drive them$161,104

U19 · FY2017 · AI · contact PI

Medical Scientist Training Program$103,224

T32 · FY2017 · GM · contact PI

Administrative Core$35,337

U19 · FY2017 · AI · contact PI

Medical Scientist Training Program$1,942,031

T32 · FY2016 · GM · contact PI

Mechanisms of repeated control of acute hepatitis C infection in humans$791,478

U19 · FY2016 · AI · contact PI

Immune correlates of acute HBV recovery with and without HIV$666,387

R01 · FY2016 · AI

Antibody-Mediated Suppression of Antiviral Inflammasome Activation$442,767

R01 · FY2016 · AI · contact PI

Scientific Core$258,610

U19 · FY2016 · AI · contact PI

Medical Scientist Training Program$255,530

T32 · FY2016 · GM · contact PI

Mechanisms of T cell control in repeated HCV infection and innate immune responses that drive them$147,701

U19 · FY2016 · AI · contact PI

Administrative Core$28,827

U19 · FY2016 · AI · contact PI

Immune correlates of acute HBV recovery with and without HIV$704,503

R01 · FY2015 · AI

Antibody-Mediated Suppression of Antiviral Inflammasome Activation$442,767

R01 · FY2015 · AI · contact PI

Scientific Core$217,879

U19 · FY2015 · AI · contact PI

Baltimore Acute Hepatitis C Cooperative Center$217,879

U19 · FY2015 · AI · contact PI

Baltimore Acute Hepatitis C Cooperative Center$750,866

U19 · FY2014 · AI · contact PI

Antibody-Mediated Suppression of Antiviral Inflammasome Activation$442,767

R01 · FY2014 · AI · contact PI

Cellular Immune Response to Acute HCV Infection$245,917

U19 · FY2014 · AI · contact PI

Scientific Core$205,828

U19 · FY2014 · AI · contact PI

Administrative Core$28,409

U19 · FY2014 · AI · contact PI

Baltimore Acute Hepatitis C Cooperative Center$705,407

U19 · FY2013 · AI · contact PI

Antibody-Mediated Suppression of Antiviral Inflammasome Activation$455,681

R01 · FY2013 · AI · contact PI

Scientific Core$213,690

U19 · FY2013 · AI · contact PI

Cellular Immune Response to Acute HCV Infection$157,326

U19 · FY2013 · AI · contact PI

Administrative Core$31,759

U19 · FY2013 · AI · contact PI

Baltimore Acute Hepatitis C Cooperative Center$751,751

U19 · FY2012 · AI · contact PI

Mechanisms of Immune Evasion by Hepatitis C Virus$401,841

R01 · FY2012 · AI · contact PI

Scientific Core$289,393

U19 · FY2012 · AI · contact PI

Cellular Immune Response to Acute HCV Infection$187,180

U19 · FY2012 · AI · contact PI

Administrative Core$24,773

U19 · FY2012 · AI · contact PI

Baltimore Acute Hepatitis C Cooperative Center$765,313

U19 · FY2011 · AI · contact PI

Mechanisms of Immune Evasion by Hepatitis C Virus$401,841

R01 · FY2011 · AI · contact PI

Scientific Core$266,901

U19 · FY2011 · AI · contact PI

Cellular Immune Response to Acute HCV Infection$188,831

U19 · FY2011 · AI · contact PI

Administrative Core$87,819

U19 · FY2011 · AI · contact PI

Baltimore Acute Hepatitis C Cooperative Center$764,565

U19 · FY2010 · AI · contact PI

Mechanisms of Immune Evasion by Hepatitis C Virus$405,900

R01 · FY2010 · AI · contact PI

Scientific Core$277,612

U19 · FY2010 · AI · contact PI

Cellular Immune Response to Acute HCV Infection$184,723

U19 · FY2010 · AI · contact PI

Administrative Core$86,462

U19 · FY2010 · AI · contact PI

Mechanisms of Immune Evasion by Hepatitis C Virus$49,446

R01 · FY2010 · AI · contact PI

Mechanisms of Immune Evasion by Hepatitis C Virus$403,000

R01 · FY2009 · AI · contact PI

Incident HIV Infection and Immune Response to Hepatitis C Virus$168,199

K08 · FY2007 · DA · contact PI

Incident HIV Infection and Immune Response to HCV$164,250

K08 · FY2006 · DA · contact PI

Incident HIV Infection and Immune Response to HCV$165,033

K08 · FY2005 · DA

Incident HIV Infection and Immune Response to HCV$143,015

K08 · FY2004 · DA

Incident HIV Infection and Immune Response to HCV$142,521

K08 · FY2003 · DA